Evidence map›Paper›PMID 42774594›Full record

ArticleClinical case reports2026

A Case of Recurrent Acute Myocardial Infarction Complicated With Idiopathic Thrombocytopenic Purpura.

Chengping Hu, Xuhe Gong

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chengping HuCenter for Coronary Heart Disease Beijing Anzhen Hospital, Capital Medical University Beijing China.
Xuhe GongCenter for Coronary Heart Disease Beijing Anzhen Hospital, Capital Medical University Beijing China.ORCID https://orcid.org/0000-0002-0513-6674

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Managing patients with immune thrombocytopenic purpura (ITP) and thrombocytopenia is challenging when they present with AMI, especially when platelets are severely decreased after interventional therapy. Our case shows that such patients, if stable, can be safely and successfully treated with glucocorticoid to improve platelet count after proceeding to invasive management and dual antiplatelet medications.

Indexed as

acute myocardial infarctionantiplatelet therapyidiopathic thrombocytopenic purpurain‐stent restenosis

Identifiers

PMID42774594
PMCPMC13594386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.